Literature DB >> 14985310

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.

Timothy J Lyons1, Alicia J Jenkins, Deyi Zheng, Daniel T Lackland, Daniel McGee, W Timothy Garvey, Richard L Klein.   

Abstract

PURPOSE: To determine associations between retinopathy status and detailed serum lipoprotein subclass profiles in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) cohort.
METHODS: Persons with type 1 diabetes (440 women, 548 men) from the DCCT/EDIC cohort were studied. Retinopathy was characterized by Early Treatment Diabetic Retinopathy Study (ETDRS) scores, hard exudate scores, and ETDRS scores minus the hard exudate component. Lipoproteins were characterized by conventional lipid profile, nuclear magnetic resonance lipoprotein subclass profile (NMR-LSP), apoA1, apoB, lipoprotein(a), and susceptibility of LDL to oxidation. Data were analyzed with and without the following covariates: age, gender, duration of diabetes, HbA(1c), albumin excretion rate (AER), creatinine clearance, hypertension, body mass index, waist-hip ratio, DCCT treatment group, smoking status.
RESULTS: The severity of retinopathy was positively associated with triglycerides (combined cohort) and negatively associated with HDL cholesterol (men, combined cohort). NMR-LSP identified retinopathy as being positively associated with small and medium VLDL and negatively with VLDL size. In men only, retinopathy was positively associated with small LDL, LDL particle concentration, apoB concentration, and small HDL and was negatively associated with large LDL, LDL size, large HDL, and HDL size. No associations were found with apoA1, Lp(a), or susceptibility of LDL to oxidation. All three measures of retinopathy revealed the same associations.
CONCLUSIONS: NMR-LSP reveals new associations between serum lipoproteins and severity of retinopathy in type 1 diabetes. The data are consistent with a role for dyslipoproteinemia involving lipoprotein subclasses in the pathogenesis of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985310     DOI: 10.1167/iovs.02-0648

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  87 in total

1.  The Renin-Angiotensin-Aldosterone System (RAAS) Is One of the Effectors by Which Vascular Endothelial Growth Factor (VEGF)/Anti-VEGF Controls the Endothelial Cell Barrier.

Authors:  Yueru Li; Zhonghao Yan; Komal Chaudhry; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2020-06-23       Impact factor: 4.307

Review 2.  Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom.

Authors:  Tunde Peto; Christine Tadros
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 3.  Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.

Authors:  Andreas Stahl; Tim U Krohne; Przemyslaw Sapieha; Jing Chen; Ann Hellstrom; Emily Chew; Frank G Holz; Lois E H Smith
Journal:  Br J Ophthalmol       Date:  2011-03-18       Impact factor: 4.638

4.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

5.  Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum.

Authors:  Ville-Petteri Mäkinen; Pasi Soininen; Carol Forsblom; Maija Parkkonen; Petri Ingman; Kimmo Kaski; Per-Henrik Groop; Mika Ala-Korpela
Journal:  MAGMA       Date:  2006-12-15       Impact factor: 2.310

6.  Oxidised, glycated LDL selectively influences tissue inhibitor of metalloproteinase-3 gene expression and protein production in human retinal capillary pericytes.

Authors:  J L Barth; Y Yu; W Song; K Lu; A Dashti; Y Huang; W S Argraves; T J Lyons
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

Review 7.  The pathologic continuum of diabetic vascular disease.

Authors:  Gabriela Orasanu; Jorge Plutzky
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

8.  Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

Authors:  Ming-Hui Zou; Hongliang Li; Chaoyong He; Mingkai Lin; Timothy J Lyons; Zhonglin Xie
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

Review 9.  Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

Authors:  Andrea M Vincent; Lucy M Hinder; Rodica Pop-Busui; Eva L Feldman
Journal:  J Peripher Nerv Syst       Date:  2009-12       Impact factor: 3.494

10.  Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.

Authors:  Ying Zhang; Alicia J Jenkins; Arpita Basu; Julie A Stoner; Maria F Lopes-Virella; Richard L Klein; Timothy J Lyons
Journal:  J Lipid Res       Date:  2015-12-09       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.